Back to today’s briefing

Story perspectives

Universal Genetic Testing Vital for Precision Oncology Expansion

1/15/2025

33 4

Summary

Story summary

Dr. Pedro Barata underscores the critical role of universal genetic testing for advanced solid tumors as tumor-agnostic therapies receive FDA nods. He points out the intricate nature of genetic testing, distinguishing between somatic and germline tests, and stresses the necessity for specialized care teams to bring precision oncology to community healthcare.

1 of 1

Story summary

Dr. Pedro Barata underscores the critical role of universal genetic testing for advanced solid tumors as tumor-agnostic therapies receive FDA nods. He points out the intricate nature of genetic testing, distinguishing between somatic and germline tests, and stresses the necessity for specialized care teams to bring precision oncology to community healthcare.